Proposed Priorities for Amendment Cycle, 28381-28382 [2017-12868]
Download as PDF
Federal Register / Vol. 82, No. 118 / Wednesday, June 21, 2017 / Notices
included in the ICR for OMB approval
of the extension of the information
collection; they will also become a
matter of public record.
Approved: June 9, 2017.
R. Joseph Durbala,
Tax Analyst, IRS.
[FR Doc. 2017–12865 Filed 6–20–17; 8:45 am]
BILLING CODE 4830–01–P
UNITED STATES SENTENCING
COMMISSION
Proposed Priorities for Amendment
Cycle
United States Sentencing
Commission.
ACTION: Notice; request for public
comment.
AGENCY:
As part of its statutory
authority and responsibility to analyze
sentencing issues, including operation
of the federal sentencing guidelines, and
in accordance with Rule 5.2 of its Rules
of Practice and Procedure, the United
States Sentencing Commission is
seeking comment on possible policy
priorities for the amendment cycle
ending May 1, 2018.
DATES: Public comment should be
received by the Commission on or
before July 31, 2017.
ADDRESSES: Comments should be sent to
the Commission by electronic mail or
regular mail. The email address is
pubaffairs@ussc.gov. The regular mail
address is United States Sentencing
Commission, One Columbus Circle NE.,
Suite 2–500, South Lobby, Washington,
DC 20002–8002, Attention: Public
Affairs—Priorities Comment.
FOR FURTHER INFORMATION CONTACT:
Christine Leonard, Director, Office of
Legislative and Public Affairs, (202)
502–4500, pubaffairs@ussc.gov.
SUPPLEMENTARY INFORMATION: The
United States Sentencing Commission is
an independent agency in the judicial
branch of the United States
Government. The Commission
promulgates sentencing guidelines and
policy statements for federal sentencing
courts pursuant to 28 U.S.C. 994(a). The
Commission also periodically reviews
and revises previously promulgated
guidelines pursuant to 28 U.S.C. 994(o)
and submits guideline amendments to
the Congress not later than the first day
of May each year pursuant to 28 U.S.C.
994(p).
The Commission provides this notice
to identify tentative priorities for the
amendment cycle ending May 1, 2018.
The Commission recognizes, however,
that other factors, such as the enactment
asabaliauskas on DSKBBXCHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:12 Jun 20, 2017
Jkt 241001
of legislation requiring Commission
action, may affect the Commission’s
ability to complete work on any or all
of its identified priorities by the
statutory deadline of May 1, 2018.
Accordingly, it may be necessary to
continue work on any or all of these
issues beyond the amendment cycle
ending on May 1, 2018.
As so prefaced, the Commission has
identified the following tentative
priorities:
(1) Continuation of its multi-year
examination of the overall structure of
the guidelines post-Booker, possibly
including recommendations to Congress
on any statutory changes and
development of any guideline
amendments that may be appropriate.
As part of this examination, the
Commission intends to study possible
approaches to (A) simplify the operation
of the guidelines, promote
proportionality, and reduce sentencing
disparities; and (B) appropriately
account for the defendant’s role,
culpability, and relevant conduct.
(2) Continuation of its multi-year
study of offenses involving MDMA/
Ecstasy, tetrahydrocannabinol (THC),
synthetic cannabinoids (such as JWH018 and AM-2201), and synthetic
cathinones (such as Methylone, MDPV,
and Mephedrone), and consideration of
any amendments to the Guidelines
Manual that may be appropriate. As part
of this examination, the Commission
more generally intends to study possible
approaches to simplify the
determination of the most closely
related substance under Application
Note 6 of the Commentary to Section
2D1.1.
(3) Continuation of its work with
Congress and other interested parties to
implement the recommendations set
forth in the Commission’s 2016 report to
Congress, titled Career Offender
Sentencing Enhancements, including its
recommendations to revise the career
offender directive at 28 U.S.C. 994(h) to
focus on offenders who have committed
at least one ‘‘crime of violence’’ and to
adopt a uniform definition of ‘‘crime of
violence’’ applicable to the guidelines
and other recidivist statutory
provisions.
(4) Continuation of its work with
Congress and other interested parties on
statutory mandatory minimum penalties
to implement the recommendations set
forth in the Commission’s 2011 report to
Congress, titled Mandatory Minimum
Penalties in the Federal Criminal Justice
System, including its recommendations
regarding the severity and scope of
mandatory minimum penalties,
consideration of expanding the ‘‘safety
valve’’ at 18 U.S.C. 3553(f), and
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
28381
elimination of the mandatory ‘‘stacking’’
of penalties under 18 U.S.C. 924(c). The
Commission also intends to release a
series of publications updating the data
in the 2011 report.
(5) Continuation of its comprehensive,
multi-year study of recidivism,
including (A) examination of
circumstances that correlate with
increased or reduced recidivism; (B)
possible development of
recommendations for using information
obtained from such study to reduce
costs of incarceration and overcapacity
of prisons, and promote effectiveness of
reentry programs; and (C) consideration
of any amendments to the Guidelines
Manual that may be appropriate,
including possibly amending Chapter
Four and Chapter Five to provide lower
guideline ranges for ‘‘first offenders’’
generally and to increase the availability
of alternatives to incarceration for such
offenders at the lower levels of the
Sentencing Table.
(6) Implementation of the Bipartisan
Budget Act of 2015, Public Law 114–74,
and any other crime legislation enacted
during the 114th or 115th Congress
warranting a Commission response.
(7) Continuation of its study of the
findings and recommendations
contained in the May 2016 Report
issued by the Commission’s Tribal
Issues Advisory Group and
consideration of any amendments to the
Guidelines Manual that may be
appropriate, including (A) revising how
tribal court convictions are addressed in
Chapter Four, and (B) providing a
definition of ‘‘court protection order’’
that would apply throughout the
guidelines.
(8) Examination of Chapter Four, Part
A (Criminal History) to study (A) how
the guidelines account for prior federal
and state convictions resulting from the
same criminal conduct under Section
4A1.2(a)(2); (B) the treatment of
convictions for offenses committed prior
to age eighteen; (C) the treatment of
revocation sentences under Section
4A1.2(k); and (D) a possible amendment
of Section 4A1.3 to account for
instances in which the time actually
served was substantially less than the
length of the sentence imposed for a
conviction counted in the criminal
history score.
(9) Continuation of its study of
alternatives to incarceration, including
(A) issuing a publication regarding the
development of alternative to
incarceration programs in federal
district courts, and (B) possibly
amending the Sentencing Table in
Chapter 5, Part A to consolidate Zones
B and C, and other relevant provisions
in the Guidelines Manual.
E:\FR\FM\21JNN1.SGM
21JNN1
28382
Federal Register / Vol. 82, No. 118 / Wednesday, June 21, 2017 / Notices
(10) Resolution of circuit conflicts,
pursuant to the Commission’s
continuing authority and responsibility,
under 28 U.S.C. 991(b)(1)(B) and
Braxton v. United States, 500 U.S. 344
(1991), to resolve conflicting
interpretations of the guidelines by the
federal courts.
(11) Consideration of any
miscellaneous guideline application
issues coming to the Commission’s
attention from case law and other
sources, including consideration of
whether a defendant’s denial of relevant
conduct should be considered in
determining whether a defendant has
accepted responsibility for purposes of
Section 3E1.1.
The Commission hereby gives notice
that it is seeking comment on these
tentative priorities and on any other
issues that interested persons believe
the Commission should address during
the amendment cycle ending May 1,
2018. To the extent practicable, public
comment should include the following:
(1) A statement of the issue, including,
where appropriate, the scope and
manner of study, particular problem
areas and possible solutions, and any
other matters relevant to a proposed
priority; (2) citations to applicable
sentencing guidelines, statutes, case
law, and constitutional provisions; and
(3) a direct and concise statement of
why the Commission should make the
issue a priority.
Authority: 28 U.S.C. 994(a), (o); USSC
Rules of Practice and Procedure 5.2.
William H. Pryor, Jr.,
Acting Chair.
[FR Doc. 2017–12868 Filed 6–20–17; 8:45 am]
BILLING CODE 2210–40–P
UNITED STATES SENTENCING
COMMISSION
Sentencing Guidelines for United
States Courts
United States Sentencing
Commission.
ACTION: Request for public comment.
AGENCY:
In August 2016, the
Commission indicated that one of its
policy priorities would be the ‘‘[s]tudy
of offenses involving MDMA/Ecstasy,
synthetic cannabinoids (such as JWH–
018 and AM–2201), and synthetic
cathinones (such as Methylone, MDPV,
and Mephedrone), and consideration of
any amendments to the Guidelines
Manual that may be appropriate in light
of the information obtained from such
study.’’ See 81 FR 58004 (Aug. 24,
2016). As part of its continuing work on
this priority, the Commission is
asabaliauskas on DSKBBXCHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:12 Jun 20, 2017
Jkt 241001
publishing this request for public
comment on issues related to MDMA/
Ecstasy and methylone, one of the
synthetic cathinones included in the
Commission’s study. The issues for
comment are set forth in the
SUPPLEMENTARY INFORMATION portion of
this notice.
DATES: Public comment regarding the
issues for comment set forth in this
notice should be received by the
Commission not later than August 7,
2017.
ADDRESSES: All written comment should
be sent to the Commission by electronic
mail or regular mail. The email address
for public comment is Public_
Comment@ussc.gov. The regular mail
address for public comment is United
States Sentencing Commission, One
Columbus Circle NE., Suite 2–500,
Washington, DC 20002–8002, Attention:
Public Affairs.
FOR FURTHER INFORMATION CONTACT:
Christine Leonard, Director, Office of
Legislative and Public Affairs, (202)
502–4500, pubaffairs@ussc.gov.
SUPPLEMENTARY INFORMATION: The
United States Sentencing Commission is
an independent agency in the judicial
branch of the United States
Government. The Commission
promulgates sentencing guidelines and
policy statements for federal courts
pursuant to 28 U.S.C. 994(a). The
Commission also periodically reviews
and revises previously promulgated
guidelines pursuant to 28 U.S.C. 994(o)
and submits guideline amendments to
the Congress not later than the first day
of May each year pursuant to 28 U.S.C.
994(p).
In August 2016, the Commission
indicated that one of its priorities would
be the ‘‘[s]tudy of offenses involving
MDMA/Ecstasy, synthetic cannabinoids
(such as JWH–018 and AM–2201), and
synthetic cathinones (such as
Methylone, MDPV, and Mephedrone),
and consideration of any amendments
to the Guidelines Manual that may be
appropriate in light of the information
obtained from such study.’’ See U.S.
Sentencing Comm’n, ‘‘Notice of Final
Priorities,’’ 81 FR 58004 (Aug. 24, 2016).
The Commission expects that this study
will be conducted over a multi-year
period, and may solicit comment several
times during this period from experts
and other members of the public.
On December 19, 2016, the
Commission published a request for
comment inviting general comment on
synthetic cathinones (MDPV,
methylone, and mephedrone) and
synthetic cannabinoids (JWH–018 and
AM–2201), as well as about the
application of the factors the
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
Commission traditionally considers
when determining the marihuana
equivalencies for specific controlled
substances to the substances under
study. See U.S. Sentencing Comm’n,
‘‘Request for Public Comment,’’ 81 FR
92021 (Dec. 19, 2016). On April 18,
2017, the Commission held a public
hearing relating to this priority. The
Commission received testimony from
experts on the synthetic drugs related to
the study, including testimony about
their chemical structure,
pharmacological effects, trafficking
patterns, and community impact.
As part of its continuing work on this
priority, the Commission is publishing
this second request for comment
specifically focused on issues related to
MDMA/Ecstasy and methylone, one of
the synthetic cathinones included in the
Commission’s study. In addition to the
substance-specific topics discussed
below, the Commission anticipates that
its work will continue to be guided by
the factors the Commission traditionally
considers when determining marihuana
equivalencies for specific controlled
substances, including their chemical
structure, pharmacological effects,
legislative and scheduling history,
potential for addiction and abuse, the
pattern of abuse and harms associated
with their abuse, and the patterns of
trafficking and harms associated with
their trafficking.
MDMA.—MDMA (3,4Methylenedioxy-methamphetamine) is a
Schedule I controlled substance with a
chemical structure similar to
methamphetamine and the hallucinogen
mescaline. See U.S. Sentencing
Comm’n, Report to the Congress:
MDMA Drug Offenses: Explanation of
Recent Guideline Amendments 6–7
(May 2001) (‘‘MDMA Report’’), available
at https://www.ussc.gov/sites/default/
files/pdf/news/congressional-testimonyand-reports/drug-topics/200105_RtC_
MDMA_Drug_Offenses.pdf. MDMA, also
known as ‘‘ecstasy’’ or ‘‘molly,’’ was
originally developed for therapeutic use,
but became a drug of abuse by the late
1970s. Id. at 7. Its use results in
enhanced feelings of pleasure,
relaxation, and self-confidence, while
accompanying physical symptoms may
include increased heart rate and blood
pressure and difficulty regulating body
temperature. MDMA is typically
marketed and consumed in pill form. Id.
MDMA is not specifically listed in the
Drug Quantity Table at § 2D1.1
(Unlawful Manufacturing, Importing,
Exporting, or Trafficking (Including
Possession with Intent to Commit These
Offenses); Attempt or Conspiracy), but it
is referenced in the Drug Equivalency
Tables. See USSC Section 2D1.1,
E:\FR\FM\21JNN1.SGM
21JNN1
Agencies
[Federal Register Volume 82, Number 118 (Wednesday, June 21, 2017)]
[Notices]
[Pages 28381-28382]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-12868]
=======================================================================
-----------------------------------------------------------------------
UNITED STATES SENTENCING COMMISSION
Proposed Priorities for Amendment Cycle
AGENCY: United States Sentencing Commission.
ACTION: Notice; request for public comment.
-----------------------------------------------------------------------
SUMMARY: As part of its statutory authority and responsibility to
analyze sentencing issues, including operation of the federal
sentencing guidelines, and in accordance with Rule 5.2 of its Rules of
Practice and Procedure, the United States Sentencing Commission is
seeking comment on possible policy priorities for the amendment cycle
ending May 1, 2018.
DATES: Public comment should be received by the Commission on or before
July 31, 2017.
ADDRESSES: Comments should be sent to the Commission by electronic mail
or regular mail. The email address is pubaffairs@ussc.gov. The regular
mail address is United States Sentencing Commission, One Columbus
Circle NE., Suite 2-500, South Lobby, Washington, DC 20002-8002,
Attention: Public Affairs--Priorities Comment.
FOR FURTHER INFORMATION CONTACT: Christine Leonard, Director, Office of
Legislative and Public Affairs, (202) 502-4500, pubaffairs@ussc.gov.
SUPPLEMENTARY INFORMATION: The United States Sentencing Commission is
an independent agency in the judicial branch of the United States
Government. The Commission promulgates sentencing guidelines and policy
statements for federal sentencing courts pursuant to 28 U.S.C. 994(a).
The Commission also periodically reviews and revises previously
promulgated guidelines pursuant to 28 U.S.C. 994(o) and submits
guideline amendments to the Congress not later than the first day of
May each year pursuant to 28 U.S.C. 994(p).
The Commission provides this notice to identify tentative
priorities for the amendment cycle ending May 1, 2018. The Commission
recognizes, however, that other factors, such as the enactment of
legislation requiring Commission action, may affect the Commission's
ability to complete work on any or all of its identified priorities by
the statutory deadline of May 1, 2018. Accordingly, it may be necessary
to continue work on any or all of these issues beyond the amendment
cycle ending on May 1, 2018.
As so prefaced, the Commission has identified the following
tentative priorities:
(1) Continuation of its multi-year examination of the overall
structure of the guidelines post-Booker, possibly including
recommendations to Congress on any statutory changes and development of
any guideline amendments that may be appropriate. As part of this
examination, the Commission intends to study possible approaches to (A)
simplify the operation of the guidelines, promote proportionality, and
reduce sentencing disparities; and (B) appropriately account for the
defendant's role, culpability, and relevant conduct.
(2) Continuation of its multi-year study of offenses involving
MDMA/Ecstasy, tetrahydrocannabinol (THC), synthetic cannabinoids (such
as JWH-018 and AM-2201), and synthetic cathinones (such as Methylone,
MDPV, and Mephedrone), and consideration of any amendments to the
Guidelines Manual that may be appropriate. As part of this examination,
the Commission more generally intends to study possible approaches to
simplify the determination of the most closely related substance under
Application Note 6 of the Commentary to Section 2D1.1.
(3) Continuation of its work with Congress and other interested
parties to implement the recommendations set forth in the Commission's
2016 report to Congress, titled Career Offender Sentencing
Enhancements, including its recommendations to revise the career
offender directive at 28 U.S.C. 994(h) to focus on offenders who have
committed at least one ``crime of violence'' and to adopt a uniform
definition of ``crime of violence'' applicable to the guidelines and
other recidivist statutory provisions.
(4) Continuation of its work with Congress and other interested
parties on statutory mandatory minimum penalties to implement the
recommendations set forth in the Commission's 2011 report to Congress,
titled Mandatory Minimum Penalties in the Federal Criminal Justice
System, including its recommendations regarding the severity and scope
of mandatory minimum penalties, consideration of expanding the ``safety
valve'' at 18 U.S.C. 3553(f), and elimination of the mandatory
``stacking'' of penalties under 18 U.S.C. 924(c). The Commission also
intends to release a series of publications updating the data in the
2011 report.
(5) Continuation of its comprehensive, multi-year study of
recidivism, including (A) examination of circumstances that correlate
with increased or reduced recidivism; (B) possible development of
recommendations for using information obtained from such study to
reduce costs of incarceration and overcapacity of prisons, and promote
effectiveness of reentry programs; and (C) consideration of any
amendments to the Guidelines Manual that may be appropriate, including
possibly amending Chapter Four and Chapter Five to provide lower
guideline ranges for ``first offenders'' generally and to increase the
availability of alternatives to incarceration for such offenders at the
lower levels of the Sentencing Table.
(6) Implementation of the Bipartisan Budget Act of 2015, Public Law
114-74, and any other crime legislation enacted during the 114th or
115th Congress warranting a Commission response.
(7) Continuation of its study of the findings and recommendations
contained in the May 2016 Report issued by the Commission's Tribal
Issues Advisory Group and consideration of any amendments to the
Guidelines Manual that may be appropriate, including (A) revising how
tribal court convictions are addressed in Chapter Four, and (B)
providing a definition of ``court protection order'' that would apply
throughout the guidelines.
(8) Examination of Chapter Four, Part A (Criminal History) to study
(A) how the guidelines account for prior federal and state convictions
resulting from the same criminal conduct under Section 4A1.2(a)(2); (B)
the treatment of convictions for offenses committed prior to age
eighteen; (C) the treatment of revocation sentences under Section
4A1.2(k); and (D) a possible amendment of Section 4A1.3 to account for
instances in which the time actually served was substantially less than
the length of the sentence imposed for a conviction counted in the
criminal history score.
(9) Continuation of its study of alternatives to incarceration,
including (A) issuing a publication regarding the development of
alternative to incarceration programs in federal district courts, and
(B) possibly amending the Sentencing Table in Chapter 5, Part A to
consolidate Zones B and C, and other relevant provisions in the
Guidelines Manual.
[[Page 28382]]
(10) Resolution of circuit conflicts, pursuant to the Commission's
continuing authority and responsibility, under 28 U.S.C. 991(b)(1)(B)
and Braxton v. United States, 500 U.S. 344 (1991), to resolve
conflicting interpretations of the guidelines by the federal courts.
(11) Consideration of any miscellaneous guideline application
issues coming to the Commission's attention from case law and other
sources, including consideration of whether a defendant's denial of
relevant conduct should be considered in determining whether a
defendant has accepted responsibility for purposes of Section 3E1.1.
The Commission hereby gives notice that it is seeking comment on
these tentative priorities and on any other issues that interested
persons believe the Commission should address during the amendment
cycle ending May 1, 2018. To the extent practicable, public comment
should include the following: (1) A statement of the issue, including,
where appropriate, the scope and manner of study, particular problem
areas and possible solutions, and any other matters relevant to a
proposed priority; (2) citations to applicable sentencing guidelines,
statutes, case law, and constitutional provisions; and (3) a direct and
concise statement of why the Commission should make the issue a
priority.
Authority: 28 U.S.C. 994(a), (o); USSC Rules of Practice and
Procedure 5.2.
William H. Pryor, Jr.,
Acting Chair.
[FR Doc. 2017-12868 Filed 6-20-17; 8:45 am]
BILLING CODE 2210-40-P